Table 3 Medical utilization and health care costs of the study population by antimigraine medication use (n = 465)
From: Antimigraine medication use and associated health care costs in employed patients
Variable | Antimigraine drug users (n = 365) | No antimigraine drug users (n = 100) | p value |
|---|---|---|---|
All-cause medical utilization | |||
 Hospitalization, n (%) | 39 (10.7) | 15 (15.0) | 0.233 |
 ED visits, n (%) | 83 (22.7) | 35 (35.0) | 0.013 |
 Total number of outpatient visits, mean (SD) | 13.2 (11.9) | 15.3 (15.6) | 0.220 |
Migraine-related medical utilization | |||
 Hospitalization, n (%) | 0 | 3 (3.0) | <0.001 |
 ED visits, n (%) | 14 (3.8) | 11 (11.0) | 0.005 |
 Total number of outpatient visits, mean (SD) | 0.8 (1.8) | 1.4 (1.2) | <0.001 |
All-cause health care costs ($), mean (median) | |||
 Medical | 7,043.7 (1921.4) | 10,450.6 (3352.0) | 0.019 |
 Pharmacy | 2,827.5 (1408.1) | 1,817.3 (753.1) | <0.001 |
 Total | 9,871.2 (4648.1) | 12,267.9 (5267.3) | 0.633 |
Migraine-related costs ($), mean (median) | |||
 Medical | 149.3 (0) | 634.1 (100.3) | <0.001 |
 Pharmacy | 516.1 (201.9) | 0 | <0.001 |
 Total | 665.4 (283.5) | 634.1 (100.3) | 0.001 |